ReP USP - Resultado da busca

Artigo de periodico
Detection and analysis of florfenicol residues and metabolites in nile tilapia (Oreochromis niloticus) tissues post-oral administration in tropical waters (2024)
Queiroga, Anna Paula R; Souza, Gabriela F. P; Paschoal, Jonas Augusto Rizzato ; Salles Junior, Airton Gonçalves; Schloter, Michael; Assane, Inácio Mateus; Pilarski, Fabiana; Gotardo, André Tadeu ; Górniak, Silvana Lima ; Rath, Susanne
Source: Journal of Veterinary Pharmacology and Therapeutics.
Subjects: TILÁPIA-DO-NILO, TEMPERATURA AMBIENTE, METABOLISMO ANIMAL, ANTIBIÓTICOS, FARMACOCINÉTICA, TILAPICULTURA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUEIROGA, Anna Paula R et al. Detection and analysis of florfenicol residues and metabolites in nile tilapia (Oreochromis niloticus) tissues post-oral administration in tropical waters. Journal of Veterinary Pharmacology and Therapeutics, 2024Tradução . . Disponível em: https://doi.org/10.1111/jvp.13485. Acesso em: 12 nov. 2024.
APA
Queiroga, A. P. R., Souza, G. F. P., Paschoal, J. A. R., Salles Junior, A. G., Schloter, M., Assane, I. M., et al. (2024). Detection and analysis of florfenicol residues and metabolites in nile tilapia (Oreochromis niloticus) tissues post-oral administration in tropical waters. Journal of Veterinary Pharmacology and Therapeutics. doi:10.1111/jvp.13485
NLM
Queiroga APR, Souza GFP, Paschoal JAR, Salles Junior AG, Schloter M, Assane IM, Pilarski F, Gotardo AT, Górniak SL, Rath S. Detection and analysis of florfenicol residues and metabolites in nile tilapia (Oreochromis niloticus) tissues post-oral administration in tropical waters [Internet]. Journal of Veterinary Pharmacology and Therapeutics. 2024 ;[citado 2024 nov. 12 ] Available from: https://doi.org/10.1111/jvp.13485
Vancouver
Queiroga APR, Souza GFP, Paschoal JAR, Salles Junior AG, Schloter M, Assane IM, Pilarski F, Gotardo AT, Górniak SL, Rath S. Detection and analysis of florfenicol residues and metabolites in nile tilapia (Oreochromis niloticus) tissues post-oral administration in tropical waters [Internet]. Journal of Veterinary Pharmacology and Therapeutics. 2024 ;[citado 2024 nov. 12 ] Available from: https://doi.org/10.1111/jvp.13485
Artigo de periodico
CYP450 metabolism of a semisynthetic naphthoquinone, an anticancer drug candidate, by human liver microsomes (2022)
Costa, Edna M. A.; Carrão, Daniel Blascke ; Bucci, Jade Lorena Mariano; Oliveira, Anderson Rodrigo Moraes de ; Machado, Tallita M.; Ferreira, Vitor F.; Lima, Émerson S.; Vasconcellos, Marne C.; Magalhães, Igor R. S.
Source: Journal of the Brazilian Chemical Society. Unidade: FFCLRP
Subjects: ANTINEOPLÁSICOS, AVALIAÇÃO DE MEDICAMENTOS, FARMACOCINÉTICA, FÁRMACOS, BIOTRANSFORMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Edna M. A. et al. CYP450 metabolism of a semisynthetic naphthoquinone, an anticancer drug candidate, by human liver microsomes. Journal of the Brazilian Chemical Society, v. 33, n. 10, p. 1145-1153, 2022Tradução . . Disponível em: https://doi.org/10.21577/0103-5053.20220034. Acesso em: 12 nov. 2024.
APA
Costa, E. M. A., Carrão, D. B., Bucci, J. L. M., Oliveira, A. R. M. de, Machado, T. M., Ferreira, V. F., et al. (2022). CYP450 metabolism of a semisynthetic naphthoquinone, an anticancer drug candidate, by human liver microsomes. Journal of the Brazilian Chemical Society, 33( 10), 1145-1153. doi:10.21577/0103-5053.20220034
NLM
Costa EMA, Carrão DB, Bucci JLM, Oliveira ARM de, Machado TM, Ferreira VF, Lima ÉS, Vasconcellos MC, Magalhães IRS. CYP450 metabolism of a semisynthetic naphthoquinone, an anticancer drug candidate, by human liver microsomes [Internet]. Journal of the Brazilian Chemical Society. 2022 ; 33( 10): 1145-1153.[citado 2024 nov. 12 ] Available from: https://doi.org/10.21577/0103-5053.20220034
Vancouver
Costa EMA, Carrão DB, Bucci JLM, Oliveira ARM de, Machado TM, Ferreira VF, Lima ÉS, Vasconcellos MC, Magalhães IRS. CYP450 metabolism of a semisynthetic naphthoquinone, an anticancer drug candidate, by human liver microsomes [Internet]. Journal of the Brazilian Chemical Society. 2022 ; 33( 10): 1145-1153.[citado 2024 nov. 12 ] Available from: https://doi.org/10.21577/0103-5053.20220034
Artigo de periodico
An appraisal of experimental designs: application to enantioselective capillary electromigration techniques (2021)
Perovani, Icaro Salgado ; Serpellone, Carolina Oliveira; Oliveira, Anderson Rodrigo Moraes de
Source: Electrophoresis. Unidade: FFCLRP
Subjects: QUÍMICA ANALÍTICA, ELETROFORESE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEROVANI, Icaro Salgado e SERPELLONE, Carolina Oliveira e OLIVEIRA, Anderson Rodrigo Moraes de. An appraisal of experimental designs: application to enantioselective capillary electromigration techniques. Electrophoresis, v. 42, n. 17-18, p. 1726-1743, 2021Tradução . . Disponível em: https://doi.org/10.1002/elps.202000334. Acesso em: 12 nov. 2024.
APA
Perovani, I. S., Serpellone, C. O., & Oliveira, A. R. M. de. (2021). An appraisal of experimental designs: application to enantioselective capillary electromigration techniques. Electrophoresis, 42( 17-18), 1726-1743. doi:10.1002/elps.202000334
NLM
Perovani IS, Serpellone CO, Oliveira ARM de. An appraisal of experimental designs: application to enantioselective capillary electromigration techniques [Internet]. Electrophoresis. 2021 ; 42( 17-18): 1726-1743.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/elps.202000334
Vancouver
Perovani IS, Serpellone CO, Oliveira ARM de. An appraisal of experimental designs: application to enantioselective capillary electromigration techniques [Internet]. Electrophoresis. 2021 ; 42( 17-18): 1726-1743.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/elps.202000334
Artigo de periodico
Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A (2021)
Tozatto, Eduardo; Benzi, Jhohann Richard de Lima ; Rocha, Adriana; Coelho, Eduardo Barbosa ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, HIPERTENSÃO, FARMACOCINÉTICA, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOZATTO, Eduardo et al. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, v. 61, n. 3, p. 319-327, 2021Tradução . . Disponível em: https://doi.org/10.1002/jcph.1745. Acesso em: 12 nov. 2024.
APA
Tozatto, E., Benzi, J. R. de L., Rocha, A., Coelho, E. B., & Lanchote, V. L. (2021). Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A. The Journal of Clinical Pharmacology, 61( 3), 319-327. doi:10.1002/jcph.1745
NLM
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/jcph.1745
Vancouver
Tozatto E, Benzi JR de L, Rocha A, Coelho EB, Lanchote VL. Nifedipine does not alter the pharmacokinetics of venlafaxine enantiomers in healthy subjects phenotyped for CYP2D6, CYP2C19, and CYP3A [Internet]. The Journal of Clinical Pharmacology. 2021 ; 61( 3): 319-327.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/jcph.1745
Artigo de periodico
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study (2021)
Brache, Vivian; Vieira, Carolina sales; Plagianos, Marlena; Lansiaux, Maud; Merkatz, Ruth; Sussman, Heather; Cochon, Leila; Tejada, Ana S; Kumar, Narender; Loeven, Daniel; Blithe, Diana L.; Aprem, Abi Santhosh; Williams, Alistair Rw; Kannan, Athilakshmi; Bagchi, Indrani C.; Sitruk-Ware, Regine
Source: Contraception. Unidade: FMRP
Subjects: ANTICONCEPÇÃO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, DISPOSITIVOS INTRAUTERINOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRACHE, Vivian et al. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study. Contraception, v. 104, n. 4, p. 327-336, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2021.06.010. Acesso em: 12 nov. 2024.
APA
Brache, V., Vieira, C. sales, Plagianos, M., Lansiaux, M., Merkatz, R., Sussman, H., et al. (2021). Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study. Contraception, 104( 4), 327-336. doi:10.1016/j.contraception.2021.06.010
NLM
Brache V, Vieira C sales, Plagianos M, Lansiaux M, Merkatz R, Sussman H, Cochon L, Tejada AS, Kumar N, Loeven D, Blithe DL, Aprem AS, Williams AR, Kannan A, Bagchi IC, Sitruk-Ware R. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study [Internet]. Contraception. 2021 ; 104( 4): 327-336.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.contraception.2021.06.010
Vancouver
Brache V, Vieira C sales, Plagianos M, Lansiaux M, Merkatz R, Sussman H, Cochon L, Tejada AS, Kumar N, Loeven D, Blithe DL, Aprem AS, Williams AR, Kannan A, Bagchi IC, Sitruk-Ware R. Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: arandomized proof-of-concept study [Internet]. Contraception. 2021 ; 104( 4): 327-336.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.contraception.2021.06.010
Artigo de periodico-carta/editorial
Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta] (2020)
Vieira, Carolina Pinto; Neves, Daniel Valente; Nardotto, Glauco Henrique Balthazar; Cesarino, Evandro José ; Rocha, Adriana; Zanardi, Ailton Marcelo Castilho Teno; Lanchote, Vera Lucia
Source: European Journal of Clinical Pharmacology. Unidade: FCFRP
Subjects: BETA-BLOQUEADORES, HIPERTENSÃO, METABOLISMO, IDOSOS, FARMACOCINÉTICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Pinto et al. Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta]. European Journal of Clinical Pharmacology. Heidelberg: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s00228-020-02837-9. Acesso em: 12 nov. 2024. , 2020
APA
Vieira, C. P., Neves, D. V., Nardotto, G. H. B., Cesarino, E. J., Rocha, A., Zanardi, A. M. C. T., & Lanchote, V. L. (2020). Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta]. European Journal of Clinical Pharmacology. Heidelberg: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1007/s00228-020-02837-9
NLM
Vieira CP, Neves DV, Nardotto GHB, Cesarino EJ, Rocha A, Zanardi AMCT, Lanchote VL. Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta] [Internet]. European Journal of Clinical Pharmacology. 2020 ; 76( 5): 735-737.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s00228-020-02837-9
Vancouver
Vieira CP, Neves DV, Nardotto GHB, Cesarino EJ, Rocha A, Zanardi AMCT, Lanchote VL. Chronic Chagas disease with low plasma concentrations of IL-6 does not have a major impact on nebivolol glucuronidation. [Carta] [Internet]. European Journal of Clinical Pharmacology. 2020 ; 76( 5): 735-737.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s00228-020-02837-9
Artigo de periodico
Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches (2020)
Santos, Kelton Luis Belém dos ; Cruz, Jorddy Neves ; Silva, Luciane B.; Ramos, Ryan S. ; Neto, Moysés F. A.; Lobato, Cleison C.; Ota, Sirlene Sayuri Barros ; Leite, Franco Henrique A. ; Borges, Rosivaldo S.; Silva, Carlos Henrique Tomich de Paula da ; Campos, Joaquín M. ; Santos, Cleydson Breno Rodrigues dos
Source: Molecules. Unidade: FCFRP
Subjects: ADENOSINA, ANTI-INFLAMATÓRIOS, FARMACOCINÉTICA, TOXICOLOGIA, INDÚSTRIA FARMACÊUTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Kelton Luis Belém dos et al. Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches. Molecules, v. 25, n. 5, p. 1-33, 2020Tradução . . Disponível em: https://doi.org/10.3390/molecules25051245. Acesso em: 12 nov. 2024.
APA
Santos, K. L. B. dos, Cruz, J. N., Silva, L. B., Ramos, R. S., Neto, M. F. A., Lobato, C. C., et al. (2020). Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches. Molecules, 25( 5), 1-33. doi:10.3390/molecules25051245
NLM
Santos KLB dos, Cruz JN, Silva LB, Ramos RS, Neto MFA, Lobato CC, Ota SSB, Leite FHA, Borges RS, Silva CHT de P da, Campos JM, Santos CBR dos. Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches [Internet]. Molecules. 2020 ; 25( 5): 1-33.[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/molecules25051245
Vancouver
Santos KLB dos, Cruz JN, Silva LB, Ramos RS, Neto MFA, Lobato CC, Ota SSB, Leite FHA, Borges RS, Silva CHT de P da, Campos JM, Santos CBR dos. Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches [Internet]. Molecules. 2020 ; 25( 5): 1-33.[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/molecules25051245
Artigo de periodico
Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach (2019)
Cusinato, Diego Alberto Ciscato ; Martinez, Edson Zangiacomi ; Cintra, Mônica T. C.; Filgueira, Gabriela Campos de Oliveira ; Berretta, Andresa A.; Lanchote, Vera Lucia ; Coelho, Eduardo Barbosa
Source: Journal of Ethnopharmacology. Unidades: FMRP, FCFRP
Subjects: PRÓPOLIS, FÁRMACOS DE ORIGEM ANIMAL, METABOLISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CUSINATO, Diego Alberto Ciscato et al. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, v. 245, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jep.2019.112174. Acesso em: 12 nov. 2024.
APA
Cusinato, D. A. C., Martinez, E. Z., Cintra, M. T. C., Filgueira, G. C. de O., Berretta, A. A., Lanchote, V. L., & Coelho, E. B. (2019). Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach. Journal of Ethnopharmacology, 245. doi:10.1016/j.jep.2019.112174
NLM
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jep.2019.112174
Vancouver
Cusinato DAC, Martinez EZ, Cintra MTC, Filgueira GC de O, Berretta AA, Lanchote VL, Coelho EB. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach [Internet]. Journal of Ethnopharmacology. 2019 ; 245[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jep.2019.112174
Artigo de periodico
Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms (2019)
Yamamoto, Priscila A.; Benzi, Jhohann Richard de Lima ; Azeredo, Francine J.; Dach, Fabiola; Ianhez Júnior, Edgar; Zanelli, Cleslei F.; Moraes, Natália V. de
Source: Basic and Clinical Pharmacology and Toxicology. Unidade: FMRP
Subjects: FARMACOGENÉTICA, GENÉTICA, POLIMORFISMO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAMAMOTO, Priscila A. et al. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms. Basic and Clinical Pharmacology and Toxicology, v. 124, n. 3, p. 266-272, 2019Tradução . . Disponível em: https://doi.org/10.1111/bcpt.13126. Acesso em: 12 nov. 2024.
APA
Yamamoto, P. A., Benzi, J. R. de L., Azeredo, F. J., Dach, F., Ianhez Júnior, E., Zanelli, C. F., & Moraes, N. V. de. (2019). Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms. Basic and Clinical Pharmacology and Toxicology, 124( 3), 266-272. doi:10.1111/bcpt.13126
NLM
Yamamoto PA, Benzi JR de L, Azeredo FJ, Dach F, Ianhez Júnior E, Zanelli CF, Moraes NV de. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms [Internet]. Basic and Clinical Pharmacology and Toxicology. 2019 ; 124( 3): 266-272.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1111/bcpt.13126
Vancouver
Yamamoto PA, Benzi JR de L, Azeredo FJ, Dach F, Ianhez Júnior E, Zanelli CF, Moraes NV de. Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: effect of OCT2 and OCTN1 gene polymorphisms [Internet]. Basic and Clinical Pharmacology and Toxicology. 2019 ; 124( 3): 266-272.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1111/bcpt.13126
Artigo de periodico
Butyl methacrylate-co-ethylene glycol dimethacrylate monolith for online in-tube SPME-UHPLC-MS/MS to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples (2019)
Beloti, Luiz Gabriel Masson; Miranda, Luis Felipe Cabral ; Queiroz, Maria Eugênia Costa
Source: Molecules. Unidade: FFCLRP
Subjects: ESQUIZOFRENIA, ANTIPSICÓTICOS, MOLÉCULA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELOTI, Luiz Gabriel Masson e MIRANDA, Luis Felipe Cabral e QUEIROZ, Maria Eugênia Costa. Butyl methacrylate-co-ethylene glycol dimethacrylate monolith for online in-tube SPME-UHPLC-MS/MS to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples. Molecules, v. 24, n. 2, p. [13] , 2019Tradução . . Disponível em: https://doi.org/10.3390/molecules24020310. Acesso em: 12 nov. 2024.
APA
Beloti, L. G. M., Miranda, L. F. C., & Queiroz, M. E. C. (2019). Butyl methacrylate-co-ethylene glycol dimethacrylate monolith for online in-tube SPME-UHPLC-MS/MS to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples. Molecules, 24( 2), [13] . doi:10.3390/molecules24020310
NLM
Beloti LGM, Miranda LFC, Queiroz MEC. Butyl methacrylate-co-ethylene glycol dimethacrylate monolith for online in-tube SPME-UHPLC-MS/MS to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples [Internet]. Molecules. 2019 ; 24( 2): [13] .[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/molecules24020310
Vancouver
Beloti LGM, Miranda LFC, Queiroz MEC. Butyl methacrylate-co-ethylene glycol dimethacrylate monolith for online in-tube SPME-UHPLC-MS/MS to determine chlopromazine, clozapine, quetiapine, olanzapine, and their metabolites in plasma samples [Internet]. Molecules. 2019 ; 24( 2): [13] .[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/molecules24020310
Artigo de periodico
An overview of biotransformation and toxicity of diterpenes (2018)
Sousa, Ingrid Pontes de ; Teixeira, Maria Valdeline Sousa; Furtado, Niege Araçari Jacometti Cardoso
Source: Molecules. Unidade: FCFRP
Subjects: BIOTRANSFORMAÇÃO, METABÓLITOS SECUNDÁRIOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Ingrid Pontes de e TEIXEIRA, Maria Valdeline Sousa e FURTADO, Niege Araçari Jacometti Cardoso. An overview of biotransformation and toxicity of diterpenes. Molecules, v. 23, n. 6, 2018Tradução . . Disponível em: https://doi.org/10.3390/molecules23061387. Acesso em: 12 nov. 2024.
APA
Sousa, I. P. de, Teixeira, M. V. S., & Furtado, N. A. J. C. (2018). An overview of biotransformation and toxicity of diterpenes. Molecules, 23( 6). doi:10.3390/molecules23061387
NLM
Sousa IP de, Teixeira MVS, Furtado NAJC. An overview of biotransformation and toxicity of diterpenes [Internet]. Molecules. 2018 ; 23( 6):[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/molecules23061387
Vancouver
Sousa IP de, Teixeira MVS, Furtado NAJC. An overview of biotransformation and toxicity of diterpenes [Internet]. Molecules. 2018 ; 23( 6):[citado 2024 nov. 12 ] Available from: https://doi.org/10.3390/molecules23061387
Artigo de periodico
Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers (2018)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro ; Coelho, Eduardo Barbosa ; Della Pasqua, Oscar; Alexandre Júnior, Veriano; Takayanagui, Osvaldo Massaiti ; Marques, Maria Paula ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, v. 149, p. 442-447, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2017.11.041. Acesso em: 12 nov. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Della Pasqua, O., Alexandre Júnior, V., Takayanagui, O. M., et al. (2018). Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers. Journal of Pharmaceutical and Biomedical Analysis, 149, 442-447. doi:10.1016/j.jpba.2017.11.041
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jpba.2017.11.041
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Júnior V, Takayanagui OM, Marques MP, Lanchote VL. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2018 ; 149 442-447.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jpba.2017.11.041
Artigo de periodico
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
Costa, A. C. C.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia; Correia, B. V.; Abumansur, Juliana Trench; Lauretti, Gabriela Rocha; Moraes, N. V. de
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOGENÉTICA, FARMACOCINÉTICA, POLIMORFISMO, BLOQUEIO NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. C. C. et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, v. 73, n. 8, p. 957-963, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00228-017-2243-1. Acesso em: 12 nov. 2024.
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Artigo de periodico
Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac (2017)
Silva, Carolina de Miranda; Rocha, Adriana; Tozatto, Eduardo; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Costa, Teresa Dalla; Lanchote, Vera Lúcia; Schmidt, Stephan; Bulitta, Jürgen B.
Source: The AAPS Journal. Unidades: FCFRP, FMRP
Subjects: FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda et al. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, v. 19, n. 6, p. 1814-1825, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0138-9. Acesso em: 12 nov. 2024.
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., Costa, T. D., et al. (2017). Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, 19( 6), 1814-1825. doi:10.1208/s12248-017-0138-9
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1208/s12248-017-0138-9
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1208/s12248-017-0138-9
Artigo de periodico
Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers (2016)
Neves, Daniel V.; Lanchote, Vera Lúcia; Moysés Neto, Miguel; Costa, José Abrão Cardeal da; Vieira, Carolina P.; Coelho, Eduardo Barbosa
Source: British Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, FARMACOCINÉTICA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Daniel V. et al. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, v. 82, n. 1, p. 83-91, 2016Tradução . . Disponível em: https://doi.org/10.1111/bcp.12917. Acesso em: 12 nov. 2024.
APA
Neves, D. V., Lanchote, V. L., Moysés Neto, M., Costa, J. A. C. da, Vieira, C. P., & Coelho, E. B. (2016). Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, 82( 1), 83-91. doi:10.1111/bcp.12917
NLM
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1111/bcp.12917
Vancouver
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1111/bcp.12917
Artigo de periodico
Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients (2016)
Godoy, Ana Leonor Pardo Campos; Rocha, Adriana; Souza, Cacilda da Silva; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: METABOLISMO, FARMACOCINÉTICA, PSORÍASE, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, v. 56, n. 5, p. 567-575, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.630. Acesso em: 12 nov. 2024.
APA
Godoy, A. L. P. C., Rocha, A., Souza, C. da S., & Lanchote, V. L. (2016). Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, 56( 5), 567-575. doi:10.1002/jcph.630
NLM
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/jcph.630
Vancouver
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/jcph.630
Artigo de periodico
Rapid and efficient method for the quantification of lychnopholide in rat plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic application (2016)
Lachi-Silva, Larissa; Sousa, João Paulo Barreto; Montanha, Maiara Camotti; Sy, Sherwin K. B.; Lopes, João Luis Callegari; Silva, Denise Brentan; Lopes, Norberto Peporine; Diniz, Andréa; Kimura, Elza
Source: Biomedical Chromatography. Unidade: FCFRP
Subjects: FARMACOCINÉTICA, COMPOSITAE, PLASMA DE ANIMAL, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACHI-SILVA, Larissa et al. Rapid and efficient method for the quantification of lychnopholide in rat plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic application. Biomedical Chromatography, v. 30, n. 7, p. 1092-1096, 2016Tradução . . Disponível em: https://doi.org/10.1002/bmc.3654. Acesso em: 12 nov. 2024.
APA
Lachi-Silva, L., Sousa, J. P. B., Montanha, M. C., Sy, S. K. B., Lopes, J. L. C., Silva, D. B., et al. (2016). Rapid and efficient method for the quantification of lychnopholide in rat plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic application. Biomedical Chromatography, 30( 7), 1092-1096. doi:10.1002/bmc.3654
NLM
Lachi-Silva L, Sousa JPB, Montanha MC, Sy SKB, Lopes JLC, Silva DB, Lopes NP, Diniz A, Kimura E. Rapid and efficient method for the quantification of lychnopholide in rat plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic application [Internet]. Biomedical Chromatography. 2016 ; 30( 7): 1092-1096.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/bmc.3654
Vancouver
Lachi-Silva L, Sousa JPB, Montanha MC, Sy SKB, Lopes JLC, Silva DB, Lopes NP, Diniz A, Kimura E. Rapid and efficient method for the quantification of lychnopholide in rat plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic application [Internet]. Biomedical Chromatography. 2016 ; 30( 7): 1092-1096.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/bmc.3654
Artigo de periodico
Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women (2015)
Filgueira, Gabriela Campos de Oliveira; Filgueira, Osmany Alberto Silva; Carvalho, Daniela Miarelli; Marques, Maria Paula; Moisés, Elaine Christine Dantas; Duarte, Geraldo; Lanchote, Vera Lúcia; Cavalli, Ricardo de Carvalho
Source: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. Unidades: FMRP, FCFRP
Subjects: FARMACOCINÉTICA, GRAVIDEZ, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, v. 993-994, p. 20-25, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.04.030. Acesso em: 12 nov. 2024.
APA
Filgueira, G. C. de O., Filgueira, O. A. S., Carvalho, D. M., Marques, M. P., Moisés, E. C. D., Duarte, G., et al. (2015). Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 993-994, 20-25. doi:10.1016/j.jchromb.2015.04.030
NLM
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Vancouver
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Analysis of nifedipine in human plasma and amniotic fluid by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics in hypertensive pregnant women [Internet]. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2015 ; 993-994 20-25.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1016/j.jchromb.2015.04.030
Artigo de periodico
Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry (2014)
Cardoso, Juciane Lauren Cavalcanti; Lanchote, Vera Lúcia; Pereira, Maria Paula Marques; Moraes, Natália Valadares de; Lepera, Jose Salvador
Source: Journal of Separation Science. Unidade: FCFRP
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES (ANÁLISE), FARMACOCINÉTICA, PLASMA, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARDOSO, Juciane Lauren Cavalcanti et al. Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry. Journal of Separation Science, v. 37, n. 8, p. 944-949, 2014Tradução . . Disponível em: https://doi.org/10.1002/jssc.201301184. Acesso em: 12 nov. 2024.
APA
Cardoso, J. L. C., Lanchote, V. L., Pereira, M. P. M., Moraes, N. V. de, & Lepera, J. S. (2014). Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry. Journal of Separation Science, 37( 8), 944-949. doi:10.1002/jssc.201301184
NLM
Cardoso JLC, Lanchote VL, Pereira MPM, Moraes NV de, Lepera JS. Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry [Internet]. Journal of Separation Science. 2014 ; 37( 8): 944-949.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/jssc.201301184
Vancouver
Cardoso JLC, Lanchote VL, Pereira MPM, Moraes NV de, Lepera JS. Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry [Internet]. Journal of Separation Science. 2014 ; 37( 8): 944-949.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/jssc.201301184
Artigo de periodico
Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats (2009)
Boralli, Vanessa Bergamin; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Chirality. Unidades: FMRP, FCFRP
Subjects: METABÓLITOS, FARMACOCINÉTICA, HIPERTENSÃO (TRATAMENTO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORALLI, Vanessa Bergamin e COELHO, Eduardo Barbosa e LANCHOTE, Vera Lúcia. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality, v. 21, n. 10, p. 886-893, 2009Tradução . . Disponível em: https://doi.org/10.1002/chir.20682. Acesso em: 12 nov. 2024.
APA
Boralli, V. B., Coelho, E. B., & Lanchote, V. L. (2009). Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats. Chirality, 21( 10), 886-893. doi:10.1002/chir.20682
NLM
Boralli VB, Coelho EB, Lanchote VL. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats [Internet]. Chirality. 2009 ; 21( 10): 886-893.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/chir.20682
Vancouver
Boralli VB, Coelho EB, Lanchote VL. Influence of quinidine, cimetidine, and ketoconazole on the enantioselective pharmacokinetics and metabolism of metoprolol in rats [Internet]. Chirality. 2009 ; 21( 10): 886-893.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1002/chir.20682

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration